DNTH
Dianthus Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +14.3% ·
aliran saham +30.0% ·
posisi baru bersih +12.5%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +12 | 36.60M | $3.56B | +16 | −4 |
| Q1 2026 | 87 | +18 | 31.37M | $2.59B | +21 | −3 |
| Q4 2025 | 69 | +2 | 26.03M | $1.07B | +3 | −1 |
| Q3 2025 | 16 | +2 | 17.27M | $679.58M | +2 | — |
| Q2 2025 | 11 | +1 | 11.18M | $208.23M | +1 | — |
| Q1 2025 | 7 | -2 | 3.50M | $63.53M | — | −2 |
| Q4 2024 | 9 | -1 | 2.27M | $49.52M | +1 | −2 |
| Q3 2024 | 9 | +3 | 1.20M | $32.83M | +4 | −1 |
| Q2 2024 | 6 | — | 1.13M | $29.26M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 5.97M | +31.4% | $234.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.58M | +3366.9% | $101.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 2.04M | +46.6% | $80.35M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasif) | 1.64M | +13.6% | $64.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 1.34M | -1.4% | $52.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.01M | +52.4% | $39.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 1.01M | +52.4% | $39.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (pasif) | 671.05K | -18.2% | $26.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Marshall Wace ✦ | 572.94K | Baru | $22.55M | 0.0% | New | 1 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasif) | 536.41K | +10.6% | $21.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (pasif) | 536.41K | +10.6% | $21.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 218.77K | — | $8.61M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 218.77K | — | $8.61M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 216.13K | +1921.5% | $8.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 216.13K | +1921.5% | $8.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 146.17K | -25.2% | $5.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 136.25K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 77.52K | — | $3.05M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Adage Capital Partners ✦ | 77.00K | -58.4% | $3.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | D. E. Shaw & Co. ✦ | 31.61K | Baru | $1.24M | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $22.55M | 0.0% |
| D. E. Shaw & Co. | $1.24M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 240 pemegang, 62.10M saham, $4.94B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 2.78K lbr · $326,554
Director · 737 lbr · $79,721
Director · 831 lbr · $90,537
Director · 272 lbr · $29,909
Director · 470 lbr · $52,194
Director · 397 lbr · $44,373
Director · 700 lbr · $77,987
Director · 70 lbr · $7,498
Director · 2.80K lbr · $303,464
Director · 1.80K lbr · $196,740
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi